In the news

This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with a number of features to improve upon the clinical performance of the original ACURATE neo platform.

Boston Scientific and IBM Research are working together to make chronic pain treatment more individualized—and effective.

“The motive is educating the community,” said Camille Chang Gilmore, global chief diversity officer at Boston Scientific. “We’ve been doing this for 16 years, and we’ve now evolved it to try and figure out how do we bring these resources to people.”

Vercise Genus, a fourth-generation system for deep brain stimulation (DBS), made by Boston Scientific, has received CE marketing and is now commercially available in Europe.

Tune in at the 33-minute mark to hear Boston Scientific’s Brian Dunkin, MD, CMO, Endoscopy, and Dave Pierce, EVP of MedSurg, discuss the EXALT™ Model D single-use duodenoscope in the DeviceTalks Weekly podcast.